Chester County News and Community Website
PHILADELPHIA, PA — Latus Bio, Inc. unveiled a significant expansion of its artificial intelligence and machine learning program as the company pushes deeper into AI-driven AAV capsid and payload design. …
Biotech Breakthrough: Latus Bio Doubles Down on AI to Revolutionize Gene Therapy Read More PHILADELPHIA, PA — Latus Bio, Inc. has announced a significant advancement in the field of gene therapy with the publication of its latest research in Nature Communications. The study, led …
Latus Bio Unveils Breakthrough in Gene Therapy for Neurodegenerative Diseases Read More PHILADELPHIA, PA — Latus Bio, Inc. has unveiled groundbreaking research on a novel adeno-associated virus (AAV) capsid variant, AAV-Ep+, which shows significant promise for advancing gene therapy applications. Published in …
Latus Bio Announces Breakthrough in Gene Therapy with AAV-Ep+ Capsid Read More PHILADELPHIA, PA — Latus Bio Inc. (Latus) will showcase its groundbreaking progress in AAV capsid variants—AAV-DB-3 and AAV-Ep+—at the 2025 American Society for Gene and Cell Therapy (ASGCT) Annual Meeting …
Latus Bio to Spotlight Advances in Gene Therapy at ASGCT Annual Meeting Read More